Disease Landscape and Forecast

Disease Landscape and Forecast, offered by Clarivate, is a market intelligence solution designed to help life sciences organisations maximise the value of their drug assets through in-depth, indication-specific insights. The product is aimed at pharmaceutical and biotech companies seeking to optimise their long-term disease strategy by leveraging comprehensive disease landscape data and actionable forecasts.

By combining detailed market assessments with expert-driven analysis, Disease Landscape and Forecast enables portfolio strategists, business development teams, and commercial leaders to make well-informed decisions about asset prioritisation, competitive positioning, and market opportunity evaluation.

Core Capabilities

• Indication-specific market intelligence providing a thorough understanding of individual disease areas
• Comprehensive disease landscape data covering the full scope of therapeutic competition and unmet need
• Actionable forecasting insights to support long-term disease and portfolio strategy
• Access to Clarivate disease experts for specialised guidance and consultation

Who It Is For

• Portfolio strategy and business development teams within pharmaceutical and biotech organisations
• Commercial and market access professionals conducting market assessments
• Life sciences companies seeking to evaluate and maximise the value of their pipeline assets

Disease Landscape and Forecast is part of Clarivate's broader suite of life sciences and healthcare intelligence solutions, which includes platforms such as Cortellis, Epidemiology Intelligence, and Market Access Intelligence, enabling organisations to integrate disease forecasting within a wider strategic intelligence workflow.